Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2024-05-03 Semiconductors
  • [Disclosure] Celltrion (068270) – Modification of Listing (Share Retirement) / 2025-04-02 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Clarification on Rumors or Reports (Unconfirmed) / 2026-07-23 Disclosures
  • [Disclosure] Hyundai Motor (005380) – (Corrected) Future Business & Management Plans / 2025-09-18 Disclosures
  • [Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Holding Announcement / 2025-02-10 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Closure of Shareholders’ Register or Setting of Record Date / 2025-12-15 Disclosures
  • [Disclosure] Celltrion (068270) – Marketing Authorization Granted by South Korean MFDS for Steqeyma (CT-P43, Stelara Biosimilar) / 2024-06-12 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract (Correction) / 2024-10-29 Disclosures

[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-08-14

Posted on August 14, 2024August 7, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Samsung Biologics announced a disclosure correction following a favorable first-instance ruling by the Seoul Administrative Court, which ruled to revoke the administrative dispositions imposed by the Securities and Futures Commission and the Financial Services Commission in 2018.

📊 [Key Disclosure Details & Summary Statistics]

  • Disclosure Type: Correction Report (Original Disclosure Date: 2018-11-28)
  • Reason for Correction: Correction of content based on court ruling
  • Corrected Items (Title & Main Content):
    • Title: (Before) Filing of Complaint and Application for Stay of Execution Regarding Dispositions by the Securities and Futures Commission and Financial Services Commission → (After) Court Ruling on the Lawsuit for Cancellation of Dispositions by the Securities and Futures Commission and Financial Services Commission
    • Fact Confirmation Date: (Before) 2018-11-27 → (After) 2024-08-14 (Date of Seoul Administrative Court judgment)
  • Summary of Corrected Content (Lawsuit Judgment Details):
    • The Seoul Administrative Court ruled in favor of the company’s claim to cancel dispositions issued by the Securities and Futures Commission and Financial Services Commission.
    • Plaintiffs: Samsung Biologics Co., Ltd., Kim Tae-han
    • Defendants: Securities and Futures Commission, Financial Services Commission
    • Judgment Details:
      1. Revoke all dispositions determined by the defendant Securities and Futures Commission on November 19, 2018, against plaintiff Samsung Biologics Co., Ltd. (Correction order for financial statement restatement, designation of auditor for 3 years, recommendation to dismiss CEO and officer in charge) and the penalty of KRW 16,000,000 imposed on plaintiff Kim Tae-han on November 23, 2018.
      2. Revoke the penalty of KRW 8,000,000,000 (KRW 8B) imposed by defendant Financial Services Commission on plaintiff Samsung Biologics Co., Ltd. on December 14, 2018.
      3. Litigation costs shall be borne by the defendants.
  • Other Key Investment Matters:
    • The fact confirmation date refers to the judgment date of the Seoul Administrative Court.
    • Details are subject to change depending on future appeals and subsequent rulings.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Tracking Defendants’ Appeal Filing and Appellate Court Proceedings

This amendment updates the 2018 filing with the first-instance court ruling in favor of the company. Monitoring whether the defendants (the Securities and Futures Commission and Financial Services Commission) file an appeal and tracking subsequent appellate court proceedings is important for understanding the final legal confirmation status of the disposition cancellations. Relevant updates can be verified through future disclosures or periodic reports.

📢 Disclaimer & Source Notice

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.

Investment Risk Warning: This material is provided strictly for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-08-14
Next Post: [Disclosure] Hanwha Aerospace (012450) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

Related Posts

  • [Disclosure] PSK Holdings (031980) – Setting of Record Date or Closure Period of Shareholder Register / 2023-12-15 Semiconductors
  • [Disclosure] SK Hynix (000660 / SKHY) -Decision on Closure of Shareholder Register (Record Date) for Cash/In-Kind Dividend  / 2026-04-22 Disclosures
  • [Disclosure] Jeju Semiconductor(080220) – (Correction) Resolution on Convening of Extraordinary General Meeting of Shareholders / 2026-05-14 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Decision on Paid-in Capital Increase / 2025-12-22 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Results of Annual General Meeting of Shareholders / 2025-03-21 Semiconductors
  • [Disclosure] Samsung Electro-Mechanics (009150) – Consolidated Earnings Announcement (Provisional) / 2026-04-30 Semiconductors
  • [Disclosure] PSK Holdings (031980) – Setting of Record Date or Closure Period of Shareholder Register / 2023-12-15 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2025-04-28 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Clarification on Rumors or News Reports (Unconfirmed) / 2024-03-06 Disclosures
  • [Disclosure] SK Square (402340) – Cash/In-Kind Dividend Decision / 2025-10-29 Semiconductors
  • [Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-05-02 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment & Securities | Solid Earnings Expansion · Momentum Check · Target Price Upgraded / 2024-07-26 Semiconductors
  • [Research] Samsung Electro-Mechanics (009150) – Shinhan Securities | High-Value Order Expansion · ASP Growth · Earnings Upward Revision / 2026-07-31 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2024-11-18 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme